Proteomics in Molecular Toxicology: Identification of Potential Early Protein Biomarkers for Hepatocarcinogenicity in Rats

Authors

  • K. Fella Merck KGaA, Institute of Toxicology,
  • M. Glückmann Applied Biosystems, Darmstadt, Germany
  • V. Kruft Applied Biosystems, Darmstadt, Germany
  • P.-J. Kramer Merck KGaA, Institute of Toxicology,
  • M. Kröger Merck KGaA, Institute of Toxicology,

Abstract

Modern proteomics technology was used for identification of protein biomarkers for hepatocarcinogenicity. It replaced currently used methods for the studies of toxic effects of drug candidates. The detection of new biomolecular markers can shorten future studies.

Downloads

Published

2006-01-15

How to Cite

Fella, K., Glückmann, M., Kruft, V., Kramer, P.-J., & Kröger, M. (2006). Proteomics in Molecular Toxicology: Identification of Potential Early Protein Biomarkers for Hepatocarcinogenicity in Rats. Chemické Listy, 99(12). Retrieved from http://w.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/1974

Issue

Vol. 99 No. 12 (2005)

Section

Articles